Related Experiment Video
Updated: May 3, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Diabetes complications and adverse health outcomes after coronary revascularization
Bola F Ekezue1, S B Laditka1, J N Laditka1
1Department of Public Health Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, United States.
Insights
Patients with diabetes complications undergoing heart revascularization (coronary artery bypass graft or percutaneous coronary intervention) face higher risks of in-hospital death and kidney failure.
Area of Science:
- Cardiology
- Endocrinology
- Health Services Research
Background:
- Diabetes mellitus is a prevalent condition associated with microvascular and macrovascular complications.
- Patients with diabetes often require revascularization procedures like coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) for coronary artery disease.
- The impact of diabetes complications on outcomes after these procedures is a critical area of investigation.
Purpose of the Study:
- To investigate the association between diabetes complications and health outcomes in patients undergoing CABG or PCI.
- To compare outcomes between diabetic patients with and without diabetes complications.
Main Methods:
- Retrospective analysis of Nationwide Inpatient Sample data from 2007, including 61,566 diabetic patients aged 45+ undergoing CABG or PCI.
- Propensity score-adjusted logistic regression was employed to control for confounding factors.
Main Results:
- 21.2% of the weighted sample had diabetes complications, more common in older, Black, Hispanic, and sicker patients.
- Diabetes complications were linked to significantly higher unadjusted and adjusted in-hospital mortality and renal failure.
- Percutaneous coronary intervention (PCI) showed an increased risk of postoperative renal failure compared to CABG specifically for patients with diabetes complications.
Conclusions:
- Diabetes complications significantly elevate the risks of in-hospital mortality and renal failure following coronary revascularization.
- These elevated risks persist regardless of whether patients undergo CABG or PCI.
- Identifying and managing diabetes complications is crucial for improving outcomes in patients undergoing cardiac procedures.
Aims:
To examine effects of diabetes complications on health outcomes following coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI), comparing outcomes for patients with diabetes complications to those without diabetes complications.
Methods:
Retrospective analysis of discharge data for 61,566 patients with diabetes age 45 or older who had CABG or PCI in 2007 in United States community hospitals, using data from the Nationwide Inpatient Sample. Analysis included propensity score-adjusted logistic regression.
Results:
Of all patients, 21.2% of the weighted sample had diabetes complications. Older patients, Blacks and Hispanics, and those with greater illness severity were more likely to have diabetes complications. Unadjusted rates of in-hospital mortality, postoperative stroke, and renal failure were higher for patients with diabetes complications (rate ratios 2.2, 1.8, and 9.8, respectively; all p<0.0001). In adjusted results, having diabetes complications was associated with higher odds of in-hospital mortality (odds ratio, OR 1.62, 95% confidence interval, CI 1.37-1.91) and renal failure (OR 3.03, CI 1.71-5.39). Compared to CABG, PCI was associated with extra risk of postoperative renal failure for those with diabetes complications.
Conclusion:
Among patients with diabetes having revascularization, those with diabetes complications have higher risks of in-hospital death and renal failure irrespective of having CABG or PCI.
More Related Videos
Related Concept Videos
Complications of Diabetes Mellitus
Diabetic Retinopathy
Diabetes: Symptoms, Diagnosis, and Complications
Coronary Artery Disease I: Introduction
Diabetic Nephropathy
Coronary Artery Disease III: Clinical Manifestations

